<DOC>
	<DOC>NCT00002359</DOC>
	<brief_summary>To determine the effect of HIV-1 immunogen (Remune) on AIDS-free survival, defined as the time prior to development of an AIDS-defining condition or death.</brief_summary>
	<brief_title>A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega</brief_title>
	<detailed_description>Patients receive 10 units of HIV-1 immunogen in IFA or IFA alone every 12 weeks, then are followed for 104-148 weeks.</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Freund's Adjuvant</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication: Allowed: Antiretrovirals if on a stable dose for at least the past 3 months. Patients must have: HIV1 infection with CD4 count 300549 cells/mm3. No AIDSdefining condition. Been on a stable dose of antiretroviral for the past 3 months, if taking antiretrovirals. NOTE: KS is permitted if not requiring systemic therapy. Prior Medication: Allowed: Prior antiretrovirals. Exclusion Criteria Concurrent Medication: Excluded: Systemic chemotherapy for KS. Treatment for malignancy other than basal cell or squamous cell carcinoma of the skin or carcinoma in situ of the cervix. Patients with the following prior conditions are excluded: History of any illness that would interfere with study. Acute infection requiring prescription therapy within the past month, other than genital herpes and oral or vaginal candidiasis. Prior Medication: Excluded: Prior HIV1 Immunogen. Unwilling to use effective safe sex practices. Active substance abuse.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 1997</verification_date>
	<keyword>Vaccines, Synthetic</keyword>
	<keyword>Viral Vaccines</keyword>
	<keyword>HIV-1</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>AIDS Vaccines</keyword>
	<keyword>Salk HIV Immunogen</keyword>
</DOC>